Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Newmont Corporation (NEM) Price & Performance

ADMA Biologics IncTrade
Newmont CorporationTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Newmont Corporation — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.18B), while Newmont Corporation trades at $119.23 (market cap $123.56B). The key difference: Newmont Corporation is far larger — about 56.7× ADMA Biologics Inc's market cap, and Newmont Corporation pays a 0.89% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMANEM
Market Cap
$2.18B$123.56B
Sector
HealthBasic Materials
52-Week High
$20.38$131.95
52-Week Low
$7.60$67.38
Enterprise Value
$2.25B$120.14B
Dividend Yield
0.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.90, down 1.59% today, with strong profitability metrics including 64.71% gross margin and 41.9% ROE. Technical indicators show a bullish trend with support at $9-10, though RSI levels suggest overbought conditions. Recent earnings show mixed results with Q4 2025 beating expectations but Q1 and Q2 2026 missing estimates. The stock faces significant legal headwinds with multiple securities fraud lawsuits filed against the company.

Despite strong fundamentals and bullish analyst consensus (88.9% buy ratings), ADMA faces substantial legal risks from ongoing securities litigation that could impact shareholder value. The company's solid profit margins and growth trajectory provide upside potential, but investors should carefully weigh litigation risks against fundamental strength.

Newmont Corporation

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Newmont Corporation

Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.

Read more on NEM